Ken Fisher’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $65.2M | Sell |
135,712
-3,087
| -2% | -$1.58M | 0.02% | 201 |
|
|
2025
Q4 | $78M | Buy |
138,799
+1,053
| +0.8% | +$598K | 0.03% | 188 |
|
|
2025
Q3 | $70.8M | Buy |
137,746
+12,399
| +10% | +$5.41M | 0.03% | 188 |
|
|
2025
Q2 | $39.3M | Sell |
125,347
-53,245
| -30% | -$16M | 0.02% | 243 |
|
|
2025
Q1 | $54.4M | Sell |
178,592
-4,761
| -3% | -$1.6M | 0.02% | 202 |
|
|
2024
Q4 | $60.9M | Buy |
183,353
+58,954
| +47% | +$20M | 0.02% | 201 |
|
|
2024
Q3 | $41.5M | Buy |
124,399
+8,012
| +7% | +$3.04M | 0.02% | 247 |
|
|
2024
Q2 | $47.9M | Sell |
116,387
-3,574
| -3% | -$1.42M | 0.02% | 231 |
|
|
2024
Q1 | $48.5M | Sell |
119,961
-137
| -0.1% | -$48.2K | 0.02% | 231 |
|
|
2023
Q4 | $36.8M | Sell |
120,098
-3,008
| -2% | -$812K | 0.02% | 251 |
|
|
2023
Q3 | $29.8M | Buy |
123,106
+1,865
| +2% | +$477K | 0.02% | 302 |
|
|
2023
Q2 | $29.1M | Sell |
121,241
-1,191
| -1% | -$247K | 0.02% | 320 |
|
|
2023
Q1 | $23M | Sell |
122,432
-17,990
| -13% | -$3.72M | 0.01% | 348 |
|
|
2022
Q4 | $29.8M | Sell |
140,422
-164,163
| -54% | -$32.8M | 0.02% | 301 |
|
|
2022
Q3 | $47.9M | Sell |
304,585
-22,920
| -7% | -$3.66M | 0.04% | 236 |
|
|
2022
Q2 | $49M | Buy |
327,505
+22,592
| +7% | +$3.27M | 0.03% | 225 |
|
|
2022
Q1 | $49.9M | Sell |
304,913
-6,400
| -2% | -$1.06M | 0.03% | 240 |
|
|
2021
Q4 | $67.8M | Sell |
311,313
-16,993
| -5% | -$3.56M | 0.04% | 220 |
|
|
2021
Q3 | $62.1M | Buy |
328,306
+35,282
| +12% | +$6.44M | 0.04% | 215 |
|
|
2021
Q2 | $51.8M | Sell |
293,024
-728
| -0.2% | -$126K | 0.03% | 229 |
|
|
2021
Q1 | $48.2M | Sell |
293,752
-2,408
| -0.8% | -$368K | 0.03% | 233 |
|
|
2020
Q4 | $41.2M | Sell |
296,160
-9,827
| -3% | -$1.24M | 0.03% | 241 |
|
|
2020
Q3 | $34.2M | Sell |
305,987
-53,247
| -15% | -$6.16M | 0.03% | 233 |
|
|
2020
Q2 | $33.4M | Sell |
359,234
-18,902
| -5% | -$1.61M | 0.03% | 231 |
|
|
2020
Q1 | $27.7M | Sell |
378,136
-38,402
| -9% | -$3.33M | 0.03% | 219 |
|
|
2019
Q4 | $35M | Buy |
416,538
+108,615
| +35% | +$8.41M | 0.04% | 217 |
|
|
2019
Q3 | $25.9M | Buy |
307,923
+7,400
| +2% | +$559K | 0.03% | 258 |
|
|
2019
Q2 | $19.7M | Buy |
300,523
+46,038
| +18% | +$2.65M | 0.02% | 296 |
|
|
2019
Q1 | $15M | Buy |
254,485
+33,108
| +15% | +$1.98M | 0.02% | 312 |
|
|
2018
Q4 | $11.7M | Buy |
221,377
+145,439
| +192% | +$7.98M | 0.02% | 324 |
|
|
2018
Q3 | $4.55M | Sell |
75,938
-23,162
| -23% | -$1.27M | 0.01% | 431 |
|
|
2018
Q2 | $4.26M | Sell |
99,100
-29,663
| -23% | -$1.2M | 0.01% | 448 |
|
|
2018
Q1 | $4.5M | Sell |
128,763
-690
| -0.5% | -$25.2K | 0.01% | 438 |
|
|
2017
Q4 | $4.69M | Hold |
129,453
| – | – | 0.01% | 431 |
|
|
2017
Q3 | $4.13M | Buy |
129,453
+25,164
| +24% | +$769K | 0.01% | 420 |
|
|
2017
Q2 | $3.02M | Buy |
104,289
+68,725
| +193% | +$1.93M | ﹤0.01% | 428 |
|
|
2017
Q1 | $1.06M | Buy |
+35,564
| New | +$1.15M | ﹤0.01% | 503 |
|
Other funds holding MEDP
VPM
VCM
WA
Ken Fisher's MEDP Position: Q1 2026 in Review
Ken Fisher reduced its Medpace (MEDP) stake by 2.2% in Q1 2026, selling an estimated $1.58M and leaving 135,712 shares worth $65.2M. The position accounts for 0.02% of the portfolio, ranked #201.
Ken Fisher first reported a position in MEDP in Q1 2017 and has held it in 37 quarters since. The position peaked at $78M in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.
- Ken Fisher held 135,712 shares of Medpace worth $65.2M as of Q1 2026.
- Ken Fisher sold 3,087 Medpace shares in Q1 2026, an estimated $1.58M.
- Medpace made up 0.02% of Ken Fisher's portfolio in Q1 2026, its #201 holding.
- Ken Fisher first reported a position in Medpace in Q1 2017 and has held it in 37 quarters since.
- Ken Fisher's Medpace position peaked at $78M in Q4 2025.
- 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.
Based on Fisher Asset Management's 13F filing for Q1 2026, filed 5 May 2026.